Pricing Log in Create free account

GeoVax Labs Inc. (GOVX) vs Silexion Therapeutics Corp (SLXN)

GeoVax Labs Inc. and Silexion Therapeutics Corp are both Biotechnology companies. GeoVax Labs Inc. and Silexion Therapeutics Corp are of similar size ($2.7M and $2.6M). Across the 9 metrics below, GeoVax Labs Inc. leads on 6 and Silexion Therapeutics Corp on 3.

Valuation

Metric GOVX SLXN Biotechnology median
P/E n/m n/m 8.50
P/S 0.17 n/m 9.71
P/B 0.60 2.34 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.08 0.04 0.64
EV/Sales (0.27) n/m 9.21
Earnings yield (2,610.83%) (14,489.87%) (33.15%)
Free cash flow yield (1,752.21%) (12,070.84%) (25.50%)

Profitability

Metric GOVX SLXN Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (891.59%) (17,021.95%) (56.36%)
Return on assets (408.79%) (277.96%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GOVX SLXN Biotechnology median
Revenue growth (TTM) 963.56% — 6.02%
EPS growth (last fiscal year) 81.41% 97.73% 30.26%
Revenue growth, 5-year CAGR 16.18% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GOVX SLXN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.54 0.94 4.72
Net debt to EBITDA 0.14 0.38 0.96

Dividend

Metric GOVX SLXN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GOVX SLXN Biotechnology median
Market cap 2.61m 2.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack